Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Partanen

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Clinical Microbiology|May 1, 1985
Selective reactivity of antibodies to human immunoglobulins G, M, and A with rubella virus proteinsP Partanen, H Seppänen, J Suni, et al.
British Journal of Cancer|January 1, 1997
Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEAC Haglund, S Ylätupa, P Mertaniemi, et al.
Journal of Virological Methods|March 1, 1988
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probesS Syrjänen, P Partanen, R Mäntyjärvi, et al.
Journal of Clinical Pathology|December 1, 1987
Screening test for rheumatic diseases: a combined enzyme immunoassay of rheumatoid factors and antibodies to DNA and extractable nuclear antigensP Kurki, M Gripenberg, P Partanen, et al.
Experimental Eye Research|June 1, 1995
Increased release of immunoreactive calcitonin gene-related peptide (CGRP) in tears after excimer laser keratectomyP Mertaniemi, S Ylätupa, P Partanen, et al.
Journal of X-Ray Science and Technology|February 11, 2011
Comparison of ultrathin x-ray window designsV P Viitanen, R Mutikainen, S Nenonen, et al.
British Journal of Cancer|February 1, 1984
Immunological detection of faecal occult blood in colorectal cancerM J Turunen, K Liewendahl, P Partanen, et al.
British Journal of Cancer|March 1, 1995
Cellular fibronectin in serum and plasma: a potential new tumour marker?S Ylätupa, C Haglund, P Mertaniemi, et al.
Mutation Research|June 1, 1985
Mutascreen, an automated bacterial mutagenicity assayK Falck, P Partanen, M Sorsa, et al.
Health Physics|December 1, 1985
Radiation doses due to long-range transport of airborne radionuclides released by a reactor accident--effects of changing dispersion conditions during transportG Nordlund, J P Partanen, J Rossi, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Clinical Microbiology|May 1, 1985
Selective reactivity of antibodies to human immunoglobulins G, M, and A with rubella virus proteinsP Partanen, H Seppänen, J Suni, et al.
British Journal of Cancer|January 1, 1997
Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEAC Haglund, S Ylätupa, P Mertaniemi, et al.
Journal of Virological Methods|March 1, 1988
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probesS Syrjänen, P Partanen, R Mäntyjärvi, et al.
Journal of Clinical Pathology|December 1, 1987
Screening test for rheumatic diseases: a combined enzyme immunoassay of rheumatoid factors and antibodies to DNA and extractable nuclear antigensP Kurki, M Gripenberg, P Partanen, et al.
Experimental Eye Research|June 1, 1995
Increased release of immunoreactive calcitonin gene-related peptide (CGRP) in tears after excimer laser keratectomyP Mertaniemi, S Ylätupa, P Partanen, et al.
Journal of X-Ray Science and Technology|February 11, 2011
Comparison of ultrathin x-ray window designsV P Viitanen, R Mutikainen, S Nenonen, et al.
British Journal of Cancer|February 1, 1984
Immunological detection of faecal occult blood in colorectal cancerM J Turunen, K Liewendahl, P Partanen, et al.
British Journal of Cancer|March 1, 1995
Cellular fibronectin in serum and plasma: a potential new tumour marker?S Ylätupa, C Haglund, P Mertaniemi, et al.
Mutation Research|June 1, 1985
Mutascreen, an automated bacterial mutagenicity assayK Falck, P Partanen, M Sorsa, et al.
Health Physics|December 1, 1985
Radiation doses due to long-range transport of airborne radionuclides released by a reactor accident--effects of changing dispersion conditions during transportG Nordlund, J P Partanen, J Rossi, et al.
Pageof 4